Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 14.09% is in line with its 5-year average of 14.00%, around the middle of its 5-year range (0.00%–37.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 27.57% below its 12-month average of 19.45%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.09%.
DEBT TO ASSETS RATIO
14.09%
DEBT TO ASSETS RATIO AVG TTM
19.45%
DEBT TO ASSETS RATIO AVG 3Y
21.07%
DEBT TO ASSETS RATIO AVG 5Y
14.00%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-27.57%
CURRENT VS 3Y AVG
-33.13%
CURRENT VS 5Y AVG
+0.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
+12706.09%
vs the sector median at left
Bionano Genomics, Inc.
Market Cap
$16.58M
Debt to Assets Ratio
14.09%
TTM Avg
19.45%
3Y Avg
21.07%
5Y Avg
14.00%
Market Cap
$16.54M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.91M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.30M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.77M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.28M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | $16.58M | 14.09% | 19.45% | 21.07% | 14.00% |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | 0.77% | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $16.22M | 0.06% | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | 0.69% | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | 0.29% | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.00% | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $18.82M | 0.26% | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | 0.05% | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.62M | 0.10% | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.55M | 0.00% | N/A | N/A | N/A |
Debt/Assets
14.1%
Debt/Equity
0.21
Current Ratio
2.48
Interest Coverage
-111.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 14.09% |
| 2026-03-31 | 26.25% |
| 2025-12-31 | 9.40% |
| 2025-09-30 | 21.75% |
| 2025-06-30 | 25.76% |
| 2025-03-31 | 23.48% |
| 2024-12-31 | 35.60% |
| 2024-09-30 | 25.70% |
| 2024-06-30 | 21.31% |
| 2024-03-31 | 23.97% |
| 2023-12-31 | 37.04% |
| 2023-09-30 | 5.58% |
| 2023-06-30 | 3.93% |
| 2023-03-31 | 3.82% |
| 2022-12-31 | 3.79% |
| 2022-09-30 | 3.21% |
| 2022-06-30 | 3.35% |
| 2022-03-31 | 3.19% |
| 2021-12-31 | 2.84% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 3.86% |
| 2020-12-31 | 27.01% |
| 2020-09-30 | 38.68% |
| 2020-06-30 | 57.76% |
| 2020-03-31 | 88.83% |
| 2019-12-31 | 66.49% |
| 2019-09-30 | 102.72% |
| 2019-06-30 | 77.04% |
| 2019-03-31 | 62.18% |
| 2018-12-31 | 36.41% |
| 2018-09-30 | 29.37% |
| 2018-06-30 | 128.69% |
| 2018-03-31 | 121.56% |
| 2017-12-31 | 66.33% |
